2 April 2025

Last updated: Sunday 30 March 2025

Research Directory

Developing radionuclide PARP inhibitors

Real world evidence is changing regulatory policy

New cancer drugs have unique mechanisms of action

A meeting of minds at AstraZeneca

RNA epigenetics is coming of age

Human gene therapy - immunogenicity perspective

Building the antibiotic pipeline

NCI and industry: Moving innovations from the lab to patients

A small molecule approach to regenerative medicine

Multi-cytokine profiles inform treatment decisions